Engineering Single-Chain Variable Fragments to Identify Pathogenic Antibodies in Heparin-Induced Thrombocytopenia
Development of engineered antibody fragments enables precise detection of pathogenic antibodies in heparin-induced thrombocytopenia, improving diagnosis and understanding of this immune-mediated blood disorder.